Optel opens new manufacturing facilities in Brazil
6 June 2017
Traceability systems provider Optel has opened new manufacturing plants in Campinas, Brazil.
The company said its new site in Sao Paulo, particularly in Campinas, was opened due to the quality of the local infrastructure, which will help in optimizing its operations.
Optel said Brazil is an important part of its mission as the country is one of the major manufacturer of pharmaceuticals, and it is in the process of implementing pharmaceutical serialisation legislation, in line with the company's expertise and solution offering.
The inauguration of Brazilian site follows the company's headquarters expansion in Canada, and its sites in Ireland and India.
The move will allow the company to meet the increasing demand for serialisation and support the fight against counterfeit pharmaceuticals and medical devices across the world.
Optel president Louis Roy said: “Our new plant in Campinas, which is almost 1200 m2, will allow us to increase production, now and in the future, because the site also offers us the possibility of expanding our facilities by more than double later on.
Campinas plant manager Amanda Neves said: “And thanks to the strong technical skills of the local workforce, our facilities in Campinas will be able to serve the entire Latin American region in terms of sales, production and system implementation.”
Optel said its sales and revenues have increased 1000% in the past few years. Since 2014, the company hired more than 500 employees globally.
The company plans to hire a further 100 direct employees at the Brazilian site.Traceability systems provider Optel has opened new manufacturing plants in Campinas, Brazil.
The company said its new site in Sao Paulo, particularly in Campinas, was opened due to the quality of the local infrastructure, which will help in optimizing its operations.
Optel said Brazil is an important part of its mission as the country is one of the major manufacturer of pharmaceuticals, and it is in the process of implementing pharmaceutical serialisation legislation, in line with the company's expertise and solution offering.
The inauguration of Brazilian site follows the company's headquarters expansion in Canada, and its sites in Ireland and India.
The move will allow the company to meet the increasing demand for serialisation and support the fight against counterfeit pharmaceuticals and medical devices across the world.
Optel president Louis Roy said: “Our new plant in Campinas, which is almost 1200 m2, will allow us to increase production, now and in the future, because the site also offers us the possibility of expanding our facilities by more than double later on.
Campinas plant manager Amanda Neves said: “And thanks to the strong technical skills of the local workforce, our facilities in Campinas will be able to serve the entire Latin American region in terms of sales, production and system implementation.”
Optel said its sales and revenues have increased 1000% in the past few years. Since 2014, the company hired more than 500 employees globally.
The company plans to hire a further 100 direct employees at the Brazilian site.
Source: pharmaproducts.packaging-business-review.com